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Abstract
Background: Ethanol inhibits proliferation in astrocytes, an effect that was recently linked to the
suppression of phosphatidic acid (PA) formation by phospholipase D (PLD). The present study
investigates ethanol's effect on the induction of apoptosis in astrocytes and the formation of
ceramide, an apoptotic signal. Evidence is presented that the formation of PA and ceramide may be
reciprocally linked during ethanol exposure.
Results: In cultured rat cortical astrocytes, ethanol (0.3–1 %, v/v) induced nuclear fragmentation
and DNA laddering indicative of apoptosis. Concomitantly, in cells prelabeled with [3H]-serine,
ethanol caused a dose-dependent, biphasic increase of the [3H]-ceramide/ [3H]-sphingomyelin ratio
after 1 and 18 hours of incubation. As primary alcohols such as ethanol and 1-butanol were shown
to inhibit the phospholipase D (PLD)-mediated formation of PA, a mitogenic lipid messenger, we
tested their effects on ceramide formation. In astrocytes prelabeled with [3H]-serine, ethanol and
1-butanol, in contrast to t-butanol, significantly increased the formation of [3H]-ceramide.
Moreover, exogenous PA, added to transiently permeabilized astrocytes, suppressed ethanol-
induced [3H]-ceramide formation. Vice versa, addition of C2-ceramide to astrocytes inhibited PLD
activity induced by serum or phorbol ester.
Conclusion: We propose that the formation of ceramide in ethanol-exposed astrocytes is
secondary to the disruption of phospholipase D signaling. Ethanol reduces the PA:ceramide ratio
in fetal astrocytes, a mechanism which likely participates in ethanol-induced glial apoptosis during
brain development.
Background
The proliferation of astrocytes is stimulated by polypep-
tide growth factors such as PDGF, EGF, bFGF and IGF-1
acting on cellular signaling pathways which involve tyro-
sine kinases, protein kinase C, and the Ras-Raf-MAP
kinase pathway [1,2]. Astroglial proliferation is also stim-
ulated by neurotransmitters such as acetylcholine and
glutamate [3,4], by direct stimulation of protein kinase C
with phorbol ester [5,6], and by peptides such as endothe-
lin and prolactin [7,8]. Astroglial proliferation is promi-
nently inhibited by ethanol both in vivo and in vitro [9-
11], and this interference likely contributes to the devel-
opment of the fetal alcohol syndrome (alcoholic embry-
opathy) (reviewed in [12]). Ethanol has been shown to
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ual astroglial mitogens including PDGF, IGF-1, acetylcho-
line and prolactin [8,13-15].
The molecular target of ethanol's antimitogenic actions in
astroyctes is not known with certainty, but inhibitory
interactions of ethanol with lipid signaling pathways have
been implicated [15]. Our group has recently reported
strong evidence that the growth-inhibitory effect of etha-
nol in astrocytes is caused by the disruption of the phos-
pholipase D (PLD) signaling pathway [16,17]. Under
physiological conditions, PLD catalyzes the hydrolysis of
phosphatidylcholine (PC) to yield phosphatidic acid (PA)
and choline. In the presence of ethanol, however, PLD
forms phosphatidylethanol (PEth), a non-physiological
phospholipid, at the expense of PA. This PLD-specific
phenomenon of transphosphatidylation is the reason
why downstream events mediated by PLD activation and
PA formation are dose-dependently inhibited in the pres-
ence of ethanol (or other primary alcohols such as 1-buta-
nol).
In our previous work, we have found that astroglial PLD
is activated by mitogenic factors including fetal calf serum
(FCS), PDGF, and phorbol ester, and we observed that
ethanol reduced both astroglial proliferation and PA for-
mation in a parallel manner. 1-butanol reduced PA for-
mation and DNA synthesis with the same potency while
t-butanol was inactive for both effects [16]. More recently,
we demonstrated that exogenous PLD as well as PA, when
introduced into the cytosol by transient permeabilization,
stimulated astroglial cell proliferation. Importantly, the
action of PLD was suppressed in the presence of ethanol
(0.3 %, v/v) while the mitogenic effect of PA was not
affected [17]. Thus, disruption of the PLD signaling path-
way by ethanol is sufficient to suppress astroglial cell
proliferation.
Recent findings from other groups are also compatible
with a central role for the PLD signaling pathway in etha-
nol toxicity in astrocytes. First, several mitogenic factors
including those that are known to be particularly sensitive
to ethanol activate PLD activity in astrocytes. This holds
true for PDGF [16], acetylcholine [5,18], glutamate [19],
phorbol esters [5,6], endothelin [20,21], and prolactin
[22]. In fact, disruption of PLD signaling by ethanol was
recently found to be responsible for ethanol's inhibitory
effect on astroglial DNA synthesis induced by muscarinic
agonist [23]. Second, PLD is activated via the mitogenic
Ras-Ral pathway in many cell types [24], and PA, the
immediate product of PLD activity, interacts with and
activates proteins such as Raf kinase, protein kinase Cζ,
and mTOR which are known to be central to mitogenic
signaling (reviewed in [25,26]). In addition, PA is a pre-
cursor of diacylglycerol (DAG), the endogenous activator
of classical PKC's, and of lyso-PA, a potent mitogen in
many cell types [25,26]. Taken together, current evidence
suggests that intact PLD signaling is a prerequisite for the
proliferative effects of several mitogens, and that disrup-
tion of the PLD pathway by ethanol may be a common
theme in ethanol-induced inhibition of astroglial
proliferation.
The present study in fetal astrocytes was motivated by
recent reports that ethanol induces apoptosis in astro-
cytes, an effect that was accompanied by activation of the
sphingomyelinase pathway and formation of ceramide
[27,28]. Apoptosis denotes an active cellular program
causing cellular death upon contact with toxicants. Apop-
totic cell death in the CNS has been under intensive study
in recent years and involves several intracellular reaction
cascades linked by the activation of caspases (reviewed in
[29]). Apoptosis is almost universally accompanied by the
formation of ceramide which may occur through de novo-
synthesis, inhibition of ceramide breakdown, or activa-
tion of (acidic and/or neutral) sphingomyelinase
(SMase), an enzyme which catalyzes the hydrolysis of
sphingomyelin to ceramide and phosphocholine (see
[30] for review). Ceramide has emerged as a second mes-
senger for apoptotic pathways targeting kinases and phos-
phatases which are required for the execution of apoptotic
cell death (reviewed in [31,32]). In cerebellar astrocytes
and in glioma cells, ceramide levels were found to be
reciprocally related to cell proliferation [33,34]. For the
present study, we developed the hypothesis that the for-
mation of ceramide may be secondary to the inhibition of
PLD signaling which we had described earlier (see above).
We now report that ethanol-induced ceramide formation
in astrocytes is mimicked by 1-butanol, but not by t-buta-
nol, and that PA, the product of PLD activity, antagonizes
ethanol-induced formation of ceramide. We also found
that ceramide is a potent inhibitor of stimulated PLD
activity. Thus, we obtained evidence of a cross-talk
between PA and ceramide, two lipid messengers with
opposite effects on cellular proliferation.
Results
Markers of apoptosis
When primary astrocyte cultures were exposed to ethanol
(0.3–1%, v/v), staining of the cells with Hoechst 33258, a
dye intercalating into DNA, revealed condensation and
fragmentation of the nuclei which was visible after 16 hrs;
the maximum effect was observed after 21 hours (Fig. 1A).
Higher magnification demonstrated the presence of
"apoptotic bodies" in the nuclei (Fig. 1B). A similar effect
was observed after treatment of the cells with the well-
known apoptogen, staurosporine (1 µM), or with C2-cera-
mide (50 µM) but not with t-butanol (1%, v/v) (not illus-
trated). In parallel experiments, ethanol caused
fragmentation of nuclear DNA in serum-starved astrocytesPage 2 of 11
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phoresis (Fig. 2). Serum withdrawal alone was not effec-
tive while incubation with C2-ceramide (50 µM)
mimicked the effect of ethanol. Ethanol at 0.3% (v/v) was
almost as effective as 1 % (Fig. 2).
Effects of ethanol on sphingomyelin hydrolysis
Formation of [3H]-ceramide was measured after labeling
sphingomyelin with [3H]serine. Under basal conditions,
the ratio of [3H]-ceramide to [3H]-sphingomyelin ("C/S
ratio") was approximately 1:30. This ratio was not signifi-
cantly changed during serum withdrawal (Figs. 3 and 4).
The incubation of astrocytes with ethanol (1 %, v/v) in
serum-free medium caused an increase of [3H]-ceramide
(cpm per dish) but did not significantly change the total
labeling of the large pool of [3H]-sphingomyelin by [3H]-
serine (data not shown). As the total incorporation of
[3H]-serine into [3H]-sphingomyelin was somewhat vari-
able between individual preparations, we used the C/S
ratio to calculate ethanol-induced changes. As shown in
Figs. 3 and 4, ethanol caused a significant increase of the
astroglial C/S ratio in a biphasic and dose-dependent
manner.
The rapid and transient phase of ceramide formation
occurred within 15 min and reached a maximum at 1
hour after addition of ethanol (1 h value without ethanol:
2.93 ± 0.35%; 1 h value with 0.3% ethanol: 3.92 ± 0.60%;
p = 0.02). A second increase gradually developed after 4
hours and reached a maximum at 18 hours of ethanol
exposure (18 h value without ethanol: 3.46 ± 0.41 %; 18
h value with ethanol: 4.18 ± 0.51 %; p = 0.005). At this
later time point, staurosporine (1 µM) caused an increase
of the C/S ratio to 7.97 ± 1.78 % (p < 0.01; not
illustrated).
Inhibition of ceramide formation by PLD activity and 
phosphatidic acid
To investigate whether ceramide formation is secondary
to a disruption of PLD signaling, we used the isomeric
Nuclear fragmentation of astrocytes after treatment with ethanolFigure 1
Nuclear fragmentation of astrocytes after treatment with ethanol. In this experiment, astrocytes were incubated with ethanol 
(1 %, v/v) for 21 hours, fixed in methanol/acetic acid (3:1) and stained with bisbenzimide (Hoechst 33258, 1 µg/ml). The charac-
teristic condensation and fragmentation of nuclei indicates apoptosis. Enlargement: left picture, 400 fold; right picture, 1,000 
fold. The experiment was repeated three times with similar results.Page 3 of 11
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butanol – is a substrate of PLD for transphosphatidylation
and leads to the formation of phosphatidyl-1-butanol at
the expense of PA. The correlations between butanol
exposures and disruption of PLD signaling (i.e., suppres-
sion of PA formation) in astrocytes were documented in
detail in our previous work [16]. In the present experi-
ments we measured the differential effects of 1- and t-
butanol on the formation of ceramide (C/S ratio) in astro-
cytes. As shown in Fig. 5, there was a tendency for an
increased level of the C/S ratio after addition of 1-butanol
at 0.1% while highly significant increases were observed
DNA fragmentation in astrocytes after treatment with ethanolFigure 2
DNA fragmentation in astrocytes after treatment with ethanol. Astrocytes were incubated with the compounds given: lane 1, 
control (serum-free medium); lane 2, serum-containing medium; lane 3, C2-ceramide (50 µM) in serum-free medium; lanes 4–
7, ethanol in serum-free medium (concentrations and times as given); lane 8, size markers. After incubation, cells were lysed, 
DNA was purified, separated on a 3 % agarose gel and stained with ethidium bromide. The experiment was repeated three 
times with identical results.Page 4 of 11
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effect. This pattern was identical at the 1 hour and 18
hours time points (Fig. 5A and 5B). This pattern suggested
a change of the C/S ratio that was secondary to the disrup-
tion of the PLD pathway.
To obtain more direct evidence for this hypothesis, we
tested the influence of exogenous PA, the product of PLD,
on the C/S ratio. For this purpose, we used a permeabili-
zation procedure which makes use of an oxygen-insensi-
tive mutant (C530A) of streptolysin-O (SL-O) to
introduce the membrane-impermeable PA into the astro-
glial cytosol [17]. In preliminary experiments, we found
that transient permeabilization with SL-O for 15 min by
itself did not affect [3H]-ceramide levels (data not shown).
Basal ceramide levels were also unchanged if exogenous
PA was added to the astrocytes in the absence (data not
shown) or presence of SL-O (Fig. 6). However, the cera-
mide formation evoked by ethanol (0.3 %) was signifi-
cantly reduced in the presence of PA (Fig. 6). At the 1 h
timepoint, the ethanol-induced effect (C/S ratio: 5.14 ±
0.53 %) was reduced by PA pretreatment to 3.98 ± 0.33 %,
a relative reduction by 71 percent (Fig. 6A). At the 18 h
timepoint, PA pretreatment reduced ethanol-induced
ceramide formation by 61 percent (Fig. 6B).
Inhibition of phospholipase D activity by ceramide
As the previous experiments indicated an inhibitory effect
of the PLD pathway on ceramide formation, the following
experiment tested a possible effect of ceramide on PLD
activity measured by the transphosphatidylation assay. In
these experiments, the membrane-permeable C2-cera-
mide (50 µM) slightly but non-significantly reduced basal
PLD activity by 30% (Fig. 7). However, when PLD activity
was stimulated by addition of serum (Fig. 7A) or by PDB,
a phorbol ester and stimulator of protein kinase C (Fig.
7B), C2-ceramide at both 10 and 50 µM strongly and
Formation of ceramide in ethanol-treated astrocytes: time c urseigur  3
Formation of ceramide in ethanol-treated astrocytes: time 
course. Astrocytes were labeled with [3H]-serine for 72 
hours, washed and treated with ethanol (0.3 %, v/v) in serum-
free medium. At the indicated time points, the cells were 
extracted with methanol/chloroform (2:1), lipid extracts 
were separated by TLC, and radioactivity associated with 
[3H]-ceramide and [3H]-sphingomyelin was determined by 
liquid scintillation counting. Data (N = 3–7) are means ± 
S.E.M. and are expressed as [%] ceramide/sphingomyelin. Sta-
tistics: ANOVA, F1,53 = 2.28, p = 0.02. *, p < 0.05 vs. control 
at time zero (Dunnett's post test).
Formation of ceramide in ethanol-treated astrocytes: con-centr dep ndencigure 4
Formation of ceramide in ethanol-treated astrocytes: con-
centration dependence. Astrocytes were labeled with 3H-
serine for 72 hours, washed and treated with ethanol (0.1–1 
%, v/v). After (A) 1 hour and (B) 18 hours, the cells were 
extracted with methanol/chloroform (2:1), phospholipids 
were separated by TLC, and the radioactivity associated with 
ceramide and sphingomyelin was determined by liquid scintil-
lation counting. Data (N = 5–6) are means ± S.E.M. and are 
expressed as [%] ceramide/sphingomyelin. Statistics: one-way 
ANOVA for repeated measurements, (A) F3,19 = 3.98, p = 
0.03; (B) F3,23 = 4.88, p = 0.02. *, p < 0.05 vs. controls (Dun-
nett's post test).Page 5 of 11
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induced PLD stimulation was more sensitive to ceramide
than PDB-induced PLD activity; the relative inhibitions
for 10 and 50 µM C2-ceramide were (for serum stimula-
tion) 84 and 93 % and (for PDB stimulation) 53 and 64
%, respectively.
Discussion
We have previously documented that ethanol suppresses
signaling through the mitogenic phospholipase D (PLD)
pathway, and we and others have provided evidence that
this effect may be responsible for the antiproliferative
actions of ethanol in astrocytes [16,17,23]. The present
study was motivated by findings that ethanol induces
astroglial apoptosis via activation of the sphingomyeli-
nase pathway [27,28]. We confirm these earlier reports by
showing the induction of apoptotic markers and ceramide
formation in ethanol-treated astrocytes. The novel finding
Effects of isomeric butanols on ceramide formation in astrocytesFigure 5
Effects of isomeric butanols on ceramide formation in astro-
cytes. Astrocytes were prelabeled with [3H]-serine for 72 
hours, washed and treated with 1-butanol ("1-But") or t-
butanol ("t-But"). After (A) 1 hour and (B) 18 hours, the 
cells were extracted with methanol/chloroform (2:1), phos-
pholipids were separated by TLC, and the radioactivity asso-
ciated with ceramide and sphingomyelin was determined by 
liquid scintillation counting. Data (N = 8–10) are means ± 
S.E.M. and are expressed as [%] ceramide/sphingomyelin. Sta-
tistics: Repeated measures ANOVA, (A) F4,49 = 7.2, p = 
0.0002; (B) F4,39 = 25.0, p < 0.0001. *, p < 0.05; **, p < 0.01 
vs. controls ("Ctr"). #, p < 0.05; ##, p < 0.01 vs. effect of 1-
butanol (Tukey-Kramer multiple comparisons test).
Effects of phosphatidic acid on ceramide formation in astrocytesFigure 6
Effects of phosphatidic acid on ceramide formation in astro-
cytes. Astrocytes were prelabeled with [3H]-serine for 72 
hours, washed and treated with PA (200 µM) or ethanol 
(EtOH, 0.3 % v/v) during transient permeabilization with 
streptolysin-O (144 ng/ml) in calcium-free medium. After 15 
min, the cultures were washed and re-exposed to calcium-
containing medium to initiate pore repair. After (A) 1 hour 
and (B) 18 hours, the cells were extracted with methanol/
chloroform (2:1), phospholipids were separated by TLC, and 
the radioactivity associated with ceramide and sphingomyelin 
was determined by liquid scintillation counting. During the 
experiments, PA was only present for 15 min during cell per-
meabilization whereas ethanol was present throughout the 
incubation period. Data (N = 9) are means ± S.E.M. and are 
expressed as [%] ceramide/sphingomyelin. Statistics: 
Repeated measures ANOVA, (A) F3,35 = 5.52, p = 0.005; (B) 
F3,35 = 14.5, p < 0.0001. **, p < 0.01 vs. controls ("Ctr"). #, p 
< 0.05; ##, p < 0.01 vs. effect of ethanol (Tukey-Kramer mul-
tiple comparisons test).Page 6 of 11
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mide is reciprocally regulated by phosphatidic acid (PA)
and the phospholipase D pathway which is itself inhib-
ited by ceramide.
We used three different approaches to demonstrate that
apoptotic cell death in astrocytes can be induced by expo-
sure to ethanol. First, we report that ethanol can induce
nuclear condensation and degradation (Fig. 1). Second,
application of ethanol to serum-starved astroglial cultures
caused "DNA laddering", a typical hallmark of apoptotic
degradation of nuclear DNA (Fig. 2). The effect of ethanol
was mimicked by a cell-permeable ceramide, C2-ceramide
(Fig. 2), and by staurosporine (not illustrated). Third, eth-
anol induced an increase of ceramide in astroglial cultures
(Figs. 3 and 4). Our findings clearly confirm that ethanol
can induce apoptosis and ceramide formation in astro-
cytes, a finding which is in agreement with some [28] but
not all [35] previous studies.
We performed a time course of [3H]-ceramide formation
after ethanol exposure and found that it was maximal at 1
and 18 hours. Biphasic formations of ceramide such as
those observed here have been described previously in a
range of peripheral cell types although their significance is
unclear; they may reflect different modes of ceramide for-
mation, or different pools of ceramide [36]. At both time
points of maximum ceramide formation (1 hour and 18
hours), we observed the same ethanol-evoked enhance-
ment of ceramide formation. Importantly, apoptotic cell
death and ceramide formation were induced by ethanol
levels as low as 65 mM which corresponds to blood alco-
hol levels (0.3%) which are found in heavy drinkers.
It should be noted that the present experiments do not
unequivocally identify the mechanism of ceramide for-
mation. We used [3H]-serine to pre-label sphingomyelin
for 72 hours, removed the precursor, and measured
formation of ceramide as an increase of the [3H]-cera-
mide/ [3H]-sphingomyelin ratio during incubations with
ethanol. This ratio most likely reflects the activity of
sphingomyelinase(s), and sphingomyelinase activity was
actually shown to be responsible for ethanol-induced
ceramide formation in a recent study [28]. However, our
present data do not exclude alternative pathways of
increased ceramide formation such as de novo-synthesis of
ceramide or inhibition of ceramidase.
The important findings of this study relate to the interac-
tion between lipid second messenger pathways. It was
known from previous work (see Introduction) that PA,
the product of phospholipase D (PLD), mediates
mitogenic stimulation in astrocytes whereas formation of
ceramide by sphingomyelinase activation accompanies
apoptosis. We now tested the hypothesis that ethanol
causes astroglial apoptosis by inhibiting PLD and, as a
consequence, stimulates the sphingomyelinase pathway.
The results shown in Figs. 5 and 6 are evidence of a direct
inhibitory influence of the PLD pathway on ceramide
formation. First, we observed that the addition of 1-buta-
Inhibition of phospholipase D activity by ceramideFigure 7
Inhibition of phospholipase D activity by ceramide. PLD activ-
ity in serum-starved, [3H]-glycerol-labeled astrocytes was 
determined by the transphosphatidylation assay; in the pres-
ence of ethanol, PLD converts [3H]-phosphatidylcholine (PC) 
into [3H]-phosphatidylethanol (PEth) which reflects PLD 
activity. In (A), PLD activity was stimulated by addition of 
medium containing 10% fetal calf serum (FCS) for 5 min. In 
(B), PLD activity was stimulated by 4β-phorbol-12β,13α-dib-
utyrate (PDB; 1 µM) for 30 min. C2-ceramide ("C2") was 
added to the cultures in concentrations of 10 and 50 µM 45 
min before the addition of FCS and PDB, respectively. Data 
are means ± S.E.M. of 7–8 experiments and are expressed as 
[%] PEth/PC. Statistics: ANOVA, (A) F4,36 = 14.0, p < 0.0001; 
(B) F4,37 = 75.2, p < 0.0001. **, p < 0.01 vs. controls. ##, p < 
0.01 vs. stimulated PLD activity (Tukey-Kramer multiple 
comparisons test).Page 7 of 11
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caused an increase of ceramide levels (Fig. 5). This effect
was not seen with the inactive isomer t-butanol which
does not interfere with PLD signaling in astrocytes (see
our previous study [16]). Second, we used transient per-
meabilization of astrocytes by streptolysin-O to introduce
PA, the product of PLD, into the astroglial cytosol [17,37].
We found that exogenous PA almost completely pre-
vented the ethanol-induced increase of ceramide at early
(1 hr) and delayed (18 hrs) phases of ceramide formation
(Fig. 6). The fact that ethanol and 1-butanol, but not t-
butanol increase ceramide formation, whereas PA antago-
nized this effect, gives strong evidence that PLD-mediated
formation of PA keeps ceramide levels low under basal
conditions (Fig. 5), and that PLD activity antagonizes
ceramide formation under the influence of toxicants (Fig.
6). Unfortunately, we could not determine the effect of
exogenous PA on astroglial apoptosis because the perme-
abilization procedure was found to induce a delayed apo-
pototic response in astrocytes (not shown).
We also probed the reciprocal effects of ceramide signal-
ing on PLD activity. The results shown in Fig. 7 demon-
strate that C2-ceramide inhibits PLD activity at a
concentration as low as 10 µM. Basal PLD activity was
only slightly inhibited, but the increases of PLD activity
induced by addition of serum or phorbol ester were
strongly antagonized. This finding in astrocytes corrobo-
rates previous reports that ceramide can inhibit PLD sign-
aling in peripheral cell types [38,39]. It remains a matter
of speculation why serum-induced PLD was somewhat
more susceptible to inhibition by ceramide than phorbol
ester-stimulated activity. Growth factors in serum and
phorbol ester may affect different signaling pathways
leading to PLD activation, and we previously presented
inhibition data with bacterial toxins which supported this
idea for astroglial PLD [40]. Interestingly, ethanol was
also observed to inhibit serum- and growth factor-medi-
ated astroglial proliferation more effectively than phorbol
ester-induced proliferation [6,16]. At this time, we cannot
distinguish which isoform of PLD is responsible for PA
formation; previous attempts to selectively down-regulate
astroglial PLDs failed due to the long biological half-lives
of the proteins [41]. The molecular target of ceramide for
inhibiting PLD also remains to be identified; previous
work has implicated direct inhibition of PLD by ceramide
as well as upstream molecules such as protein kinase C
which activate PLD [42,43].
Conclusions
In summary, the present results give evidence of a cross-
talk between lipid-signaling pathways in astrocytes such
that the product of PLD, namely PA, inhibits ceramide for-
mation whereas ceramide inhibits PLD activation (Fig. 8).
The experimental evidence suggests that the ratio
"PA:ceramide" contributes to the decision whether astro-
cytes proliferate or undergo apoptosis. Our data suggest
that ethanol induces astroglial apoptosis during brain
development by disrupting PLD signaling, thereby reduc-
ing PA and increasing ceramide formation. This effect
likely contributes to the microencephaly and delay of
brain development observed in fetal alcohol syndrome.
Methods
Materials
[3H]-Serine and [3H]-glycerol were from Biotrend (Köln,
Germany). Ceramide (from bovine brain), C2-ceramide
(N-acetyl-D-erythro-sphingosine), and staurosporine were
from Alexis (Lausen, Switzerland). Hoechst 33258, L-α-
phosphatidic acid (sodium salt, from egg yolk) and 4β-
phorbol-12β,13α-dibutyrate (PDB) were from Sigma
(Deisenhofen, Germany); most other chemicals and TLC
plates were obtained from Merck (Darmstadt, Germany)
or Roth (Karlsruhe, Germany) at the highest purity avail-
able. Fetal calf serum (South America) was from Invitro-
gen, cell culture materials were from Sarstedt
(Nürnbrecht, Germany). Phosphatidylethanol (PEth)
Hypothetical cross-talk between phospholipase D and sphin-gomyelin p thway  in astrocyt s, and effect of ethanolFigure 8
Hypothetical cross-talk between phospholipase D and sphin-
gomyelin pathways in astrocytes, and effect of ethanol. Phos-
phatidic acid (PA), the product of phosphatidylcholine (PC) 
hydrolysis by phospholipase D (PLD), inhibits hydrolysis of 
sphingomyelin (SM) by sphingomyelinase (SMase). Vice versa, 
ceramide (Cer), the product of SM hydrolysis by SMase, 
inhibits activation of PLD. Ethanol induces apoptosis by dis-
rupting the mitogenic PLD signaling pathway thereby 
decreasing the PA:Cer ratio and disinhibiting the pro-apop-
totic SMase pathway.Page 8 of 11
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oxygen-insensitive streptolysin-O (C530A) was prepared
as described [44].
Cell culture
Astrocyte-rich cultures were prepared from newborn rat
pups. Cerebral hemispheres were collected, meninges and
blood vessels were removed, the brain tissue was dissoci-
ated by trituration, passed through a 50 µm nylon mesh,
and the cells were seeded onto plastic culture dishes
(14,000 cells per cm2). The growth medium was DMEM
containing 10% fetal calf serum (FCS), 2 g/l NaHCO3,
100 U/ml penicillin and 100 µg/ml streptomycin. The
cells were incubated at 37°C in a 95/5% mixture of air
and carbon dioxide. For the experiments, astrocytes were
grown for two weeks in culture and were used when they
reached confluency. As judged by GFAP immunostaining,
these cultures contained >90% astrocytes.
Fluorescence microscopy
Cells were seeded on microplates (5,000 cells per 200 µl)
and incubated with different apoptogens (ethanol 0.3 and
1 %, C2-ceramide 50 µM or staurosporine 1 µM) for 24 hrs
in serum-free medium. Subsequently, cells were washed
and fixed with ice-cold methanol/acetic acid (3:1). Dried
and re-hydrated cells were stained with bisbenzimide
(Hoechst 33258, 1 µg/ml) solution for 10 min, washed
and sealed in gelatin. Photographs were obatined using a
Leica Leitz DMRB fluorescence microscope and a Nikon
Digital Camera DXM.
DNA fragmentation
The test was carried out as described [45] with some mod-
ifications. Briefly, cells were incubated with apoptogens
(Ethanol 0,3%, 1%; C2-Ceramide 50 µM) in serum-free
medium. Then, the cells were transferred and resuspended
in Tris-EDTA buffer containing 0.5% Igepal CA 630.
Further lysis was performed in buffer containing RNAse A
(100 µg/µl), proteinase K (0,5 µg/ml) and SDS (1.2 %).
After 5 minutes, the clear solution was mixed with 3 M
CsCl in acetate buffer. Precipitated debris and chromo-
somal DNA was removed by centrifugation, and the
supernatant was loaded onto a QIAprep column (twice),
centrifuged and eluted by hypotonic Tris-EDTA buffer.
The eluate was analyzed by electrophoresis on a 3 % aga-
rose gel and visualized with ethidium bromide.
Measurement of [3H]-ceramide formation
Phospholipids were labeled by addition of [3H]-serine (1
µCi/ml) to astrocytes kept in growth medium (DMEM
plus FCS) for 72 h. After washing, cells were incubated in
serum-free medium with ethanol, butanol, C2-ceramide
or staurosporine (see Results). C2-ceramide or stau-
rosporine were added in DMSO; the final DMSO concen-
tration was < 0.1 %. At the end of the incubation, cells
were fixed with methanol, transferred and extracted first
with with chloroform: methanol (1:1), then with chloro-
form: methanol: water (10:10:9) to separate water and
lipid phases. After addition of ceramide and
sphingomyelin standards, the lower (lipid) phase was
evaporated, taken up in chloroform:methanol (3:2) and
separated by thin-layer chromatography (TLC). For the
determination of [3H]-ceramide, we used one-dimen-
sional TLC (HP-TLC plates Merck 11845; eluent: chloro-
form/acetic acid 9:1). For the determination of [3H]-
sphingomyelin, we used two-dimensional TLC (TLC
plates Merck 1.05721); solvent I was chloroform/metha-
nol/25% aqueous ammonia (13:7:1), solvent II was chlo-
roform/ methanol/water/acetic acid (30:30:2:5). 3H-
lipids were visualized by using iodine vapor, spots were
scraped and suspended in scintillation cocktail (Lumasafe
Plus), and radioactivity was measured by liquid scintilla-
tion counting (Packard 1600 CA). Formation of [3H]-cera-
mide was calculated as percentage of radioactivity found
in [3H]-sphingomyelin.
Cell permeabilization
For the introduction of PA, astrocytes were transiently per-
meabilized with streptolysin-O [37]. Briefly, astrocytes
were washed and exposed to an oxygen-insensitive
mutant of streptolysin-O (C530A) in calcium-free HBSS
buffer (prepared by dissolving 8 g NaCl, 0.4 g KCl, 60 mg
KH2PO4, 60 mg Na2HPO4 × 2 H2O, 100 mg glucose in 1
L of sterile water). PA (sodium salt; 200 µM) was added as
a suspension in buffer prepared by sonication. After 15
min, the cells were washed and incubated in serum-free,
calcium-containing DMEM. Formation of [3H]-ceramide
was determined as described above. Ethanol, if present,
was present throughout the incubation period. Using 144
ng/ml of streptolysin-O, this procedure yielded transient
permeabilization of > 80% of astrocytes followed by
repair of the pore in > 80% of permeabilized cells. The
procedure was previously found to allow the entry of
approx. 106 molecules of PA per cell [17].
Determination of phospholipase D activity
Phospholipase D activity was determined using the
transphosphatidylation assay [46]. For this purpose,
astrocytes were kept in serum-free medium containing
[3H]-glycerol (1 µCi/ml) for 24 h in order to label phos-
pholipids. More than 60% of the phospholipid label was
associated with phosphatidylcholine (not illustrated).
Subsequently, the cells were washed and re-exposed to
medium containing ethanol (2 %) and PDB (1.0 µM) or
FCS (10 %, v/v) as stimulators. PDB and C2-ceramide,
when used, were dissolved in DMSO (end concentration
of DMSO < 0.1 %). After 30 min of reaction time, the cells
were washed in cold phosphate-buffered saline and
extracted as described above for ceramide determinations.
After addition of phosphatidylethanol (PEth) and PAPage 9 of 11
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two-dimensional TLC (TLC plate Merck 1.05721) using
chloroform/methanol/25 % aqueous ammonia (13:7:1)
for the first run and the upper phase of ethylacetate/isooc-
tane/ acetic acid/water (13:2:3:10) for the second run.
Individual phospholipids were stained by iodine, and the
spots corresponding to PEth, PA and phosphatidylcholine
(PC) were isolated and counted for radioactivity in a scin-
tillation counter. To determine PLD activity, formation of
[3H]- PEth was calculated as percentage of [3H]-PC.
Statistics
Data are shown as means ± SEM of N experiments
whereby N refers to the number of different astroglial
preparations from different animals. Results were
obtained from two replicate dishes which were pooled to
represent a single experiment. Statistical calculations were
performed by GraphPad InStat 3.0 program package,
using analysis of variance (ANOVA) of paired or unpaired
data as indicated in text and figure legends.
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